Cohort Construction and Prognostic Model Construction for Multiple Myeloma - Trial NCT06366802
Access comprehensive clinical trial information for NCT06366802 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital of Soochow University and is currently Recruitment Completed. The study focuses on Multiple Myeloma. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
The First Affiliated Hospital of Soochow University
Timeline & Enrollment
N/A
May 03, 2022
May 02, 2027
Primary Outcome
Overall survival
Summary
Multiple myeloma (MM) is a disease caused by malignant plasma cell proliferation disorder.
 Survival outcomes continue to vary widely even within uniformly treated clinical trial
 populations. How to construct a clinical prognosis model of MM through real-world data to
 guide the selection of treatment options, standardize patient management, and improve
 survival expectations, is a major problem that needs to be solved urgently. It is necessary
 to build an MM-specific cohort in China to comprehensively understand the characteristics of
 MM patients, explore treatment options, and improve prognostic factors for survival outcomes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06366802
Non-Device Trial